ImmixBio Completes GMP Manufacturing of Scaled-Up Batch of IMX-110 for Clinical Trials

ImmixBio Completes GMP Manufacturing of Scaled-Up Batch of IMX-110 for Clinical Trials

Immix Biopharma, Inc. (NASDAQ:IMMX)

Format

JPEG

Source

Immix Biopharma, Inc.

Téléchargements